Theralink Technologies Inc Revenue Growth Rates (OBMP), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Theralink Technologies Inc   (OBMP)
 

OBMP's Revenue Growth by Quarter and Year

Theralink Technologies Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OBMP Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter September -
3rd Quarter June -
2nd Quarter March -
1st Quarter December 0.08
FY 0.08





OBMP Revenue first quarter 2024 Y/Y Growth Comment
Theralink Technologies Inc reported drop in Revenue in the first quarter 2024 by -72.92% to $ 0.08 millions, from the same quarter in 2023.
The fall in the first quarter 2024 Theralink Technologies Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 109.68%.

Looking into first quarter 2024 results within Major Pharmaceutical Preparations industry 213 other companies have achieved higher Revenue growth. While Theralink Technologies Inc ' s Revenue meltdown of -72.92% ranks overall at the positon no. 3896 in the first quarter 2024.


OBMP Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter September - 25 % 23.08 % -
3rd Quarter June - 750 % 100 % -
2nd Quarter March - -25 % 60 % -
1st Quarter December -72.92 % 10.71 % - -
FY   - 37.04 % 184.21 % -

Financial Statements
Theralink Technologies Inc 's first quarter 2024 Revenue $ 0.08 millions OBMP's Income Statement
Theralink Technologies Inc 's first quarter 2023 Revenue $ 0.31 millions Quarterly OBMP's Income Statement


OBMP Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter September - 17.65 % 700 % 1200 %
3rd Quarter June - 183.33 % -75 % -80 %
2nd Quarter March - -80.65 % -71.43 % -
1st Quarter December -58.03 % 93.75 % 115.38 % -
FY (Year on Year)   - 37.04 % 184.21 % -


Back to OBMP Growth rate Comparisons >> Back to OBMP Growth rate Comparisons >>


Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #214
Healthcare Sector #556
Overall #3896

Revenue Y/Y Growth Statistics
High Average Low
770.7 % 109.68 % -100 %
(Mar 31 2023)   (Sep 30 2018)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #214
Healthcare Sector #556
Overall #3896
Revenue Y/Y Growth Statistics
High Average Low
770.7 % 109.68 % -100 %
(Mar 31 2023)   (Sep 30 2018)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Theralink Technologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1190.23 % 310.21 % -81.88 %
(Mar 31 2021)  


OBMP's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Theralink Technologies Inc disclosed fall in Revenue from the fourth quarter by -58.03% to $ 0.08 millions, from $ 0.20 millions achived in the previous reporting period.

Although periodic circumstance commonly energize I. Quarter 2024 Revenue, this plainly could not be substantial to rescue Major Pharmaceutical Preparations's company achievement, Most analysts pointed out.

Within Major Pharmaceutical Preparations industry 207 other companies have achieved higher Revenue quarter on quarter growth. While Theralink Technologies Inc 's Revenue growth quarter on quarter, overall rank is 3537.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #208
Healthcare Sector #549
Overall #3537
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #208
Healthcare Sector #549
Overall #3537
Revenue Q/Q Growth Statistics
High Average Low
1190.23 % 310.21 % -81.88 %
(Mar 31 2021)  


OBMP's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Theralink Technologies Inc disclosed fall in Revenue from the fourth quarter by -58.03% to $ 0.08 millions, from $ 0.20 millions achived in the previous reporting period.

Although periodic circumstance commonly energize I. Quarter 2024 Revenue, this plainly could not be substantial to rescue Major Pharmaceutical Preparations's company achievement, Most analysts pointed out.

Within Major Pharmaceutical Preparations industry 207 other companies have achieved higher Revenue quarter on quarter growth. While Theralink Technologies Inc 's Revenue growth quarter on quarter, overall rank is 3537.


Theralink Technologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 0.51 $ 0.73 $ 0.69 $ 0.54 $ 0.57
Y / Y Revenue Growth (TTM) -9.94 % 35.29 % 37.88 % 10.17 % 21.86 %
Year on Year Revenue Growth Overall Ranking # 1331 # 1611 # 1542 # 1283 # 0
Seqeuential Revenue Change (TTM) -30.2 % 5.51 % 27.61 % -4.17 % 4.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 1814 # 1848 # 2138 # 1745 # 1727


Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2023 Theralink Technologies Inc reported a decrease in Revenue by -9.94% year on year, to $1 millions, compare to the 35.29% growth at Jun 30 2023.

In the Healthcare sector 257 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1331, from total ranking in previous quarter at 1611.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 119
Healthcare Sector # 258
Overall # 1331

Revenue TTM Y/Y Growth Statistics
High Average Low
37.88 %
 18.35 %
-9.94 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 119
Sector # 320
S&P 500 # 1814
Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2023 Theralink Technologies Inc reported a decrease in Revenue by -9.94% year on year, to $1 millions, compare to the 35.29% growth at Jun 30 2023.

In the Healthcare sector 257 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1331, from total ranking in previous quarter at 1611.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 119
Healthcare Sector # 258
Overall # 1331

Revenue TTM Y/Y Growth Statistics
High Average Low
37.88 %
18.35 %
-9.94 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 119
Sector # 320
S&P 500 # 1814




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OBMP's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
Nrc Health-0.37%$ -0.375 millions
Skinhealth Systems Inc -0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Enhabit Inc -0.95%$ -0.950 millions
Viatris Inc -1.00%$ -0.998 millions
Aspira Women s Health inc -1.07%$ -1.068 millions
Supernus Pharmaceuticals inc -1.80%$ -1.801 millions
Opko Health Inc -1.85%$ -1.853 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc -2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Ideaya Biosciences Inc -2.46%$ -2.461 millions
Zynex inc -3.11%$ -3.114 millions
Shl Telemedicine Ltd-3.26%$ -3.259 millions
Pediatrix Medical Group Inc -3.39%$ -3.386 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Sensus Healthcare Inc -4.11%$ -4.106 millions
Outset Medical Inc -4.17%$ -4.168 millions
Journey Medical Corp-4.44%$ -4.441 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Waters Corporation-4.55%$ -4.547 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
Biolase Inc -4.68%$ -4.683 millions
American Shared Hospital Services-4.73%$ -4.725 millions


About Theralink Technologies Inc Revenue Growth Rates (OBMP), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Theralink Technologies Inc (CIK 1362703).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-24-007204
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Theralink Technologies Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.